These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1296037)

  • 41. Differentiation of iron deficiency and the anemia of chronic disease.
    Christensen DJ
    J Fam Pract; 1985 Jan; 20(1):35-9. PubMed ID: 3965599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial.
    Barraclough KA; Brown F; Hawley CM; Leary D; Noble E; Campbell SB; Isbel NM; Mudge DW; van Eps CL; Johnson DW
    Nephrol Dial Transplant; 2012 Nov; 27(11):4146-53. PubMed ID: 22962411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Storage Iron Turnover from a New Perspective.
    Saito H
    Acta Haematol; 2019; 141(4):201-208. PubMed ID: 30943466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of systemic inflammation and brain iron deposition in Parkinson's disease patients.
    Xu J; He X; Xu Y; Chen X; Li M; Zhang L; Fu X; Pan M; Wang Q; Hu X
    Ann Clin Transl Neurol; 2022 Mar; 9(3):276-285. PubMed ID: 35078271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Case-control study of markers of oxidative stress and metabolism of blood iron in Parkinson's disease].
    Larumbe Ilundáin R; Ferrer Valls JV; Viñes Rueda JJ; Guerrero D; Fraile P
    Rev Esp Salud Publica; 2001; 75(1):43-53. PubMed ID: 11400414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Iron stores, iron deficiency and iron supplementation].
    Wiggers P; Dalhøj J; Nielsen GD; Grandjean PA; Hørder M
    Ugeskr Laeger; 1991 Feb; 153(9):646-8. PubMed ID: 2008756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iron studies in infants born to an iron overloaded mother with beta-thalassemia major: possible effects of maternal desferrioxamine therapy.
    Pearson HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):160-2. PubMed ID: 17356394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evaluation of iron status in women with pregnancy complicated by tobacco smoking].
    Laskowska-Klita T; Szymborski J; Szymczak E; Czerwińska B; Chazan B
    Med Wieku Rozwoj; 2000; 4(2):119-29. PubMed ID: 11013867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety of intravenous injection of iron saccharate in haemodialysis patients.
    Sunder-Plassmann G; Hörl WH
    Nephrol Dial Transplant; 1996 Sep; 11(9):1797-802. PubMed ID: 8918625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of iron deficiency in pregnant women by determining iron status.
    Raza N; Sarwar I; Munazza B; Ayub M; Suleman M
    J Ayub Med Coll Abbottabad; 2011; 23(2):36-40. PubMed ID: 24800338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of serum iron, total iron binding capacity, ferritin, and percent transferrin saturation in nine species of apparently healthy captive lemurs.
    Williams CV; Campbell J; Glenn KM
    Am J Primatol; 2006 May; 68(5):477-89. PubMed ID: 16550526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Determination of serum ferritin: ideas for avoiding induced ferropenia in blood donors].
    Hernández Lamas MC; López Pérez-Lanzac JC; Prat Arrojo I; Sánchez Gordo F; Arleth Christensen E; Sánchez Font E
    Sangre (Barc); 1994 Feb; 39(1):9-14. PubMed ID: 8197526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood donations, iron stores, and risk of Parkinson's disease.
    Logroscino G; Chen H; Wing A; Ascherio A
    Mov Disord; 2006 Jun; 21(6):835-8. PubMed ID: 16453313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Transferrin and ferritin as laboratory indices of body iron deposits].
    Bobilewicz D; Jabłońska E; Iwanowska M; Zborowska H; Jasińska A
    Pol Tyg Lek; 1995 Oct; 50(40-44):42-4. PubMed ID: 8650058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The rise in the total iron-binding capacity after iron overdose.
    Burkhart KK; Kulig KW; Hammond KB; Pearson JR; Ambruso D; Rumack B
    Ann Emerg Med; 1991 May; 20(5):532-5. PubMed ID: 2024794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eryptosis as a marker of Parkinson's disease.
    Pretorius E; Swanepoel AC; Buys AV; Vermeulen N; Duim W; Kell DB
    Aging (Albany NY); 2014 Oct; 6(10):788-819. PubMed ID: 25411230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biological fluid levels of iron and iron-related proteins in Parkinson's disease: Review and meta-analysis.
    Jiménez-Jiménez FJ; Alonso-Navarro H; García-Martín E; Agúndez JAG
    Eur J Neurol; 2021 Mar; 28(3):1041-1055. PubMed ID: 33098743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence-Based Discriminant Analysis: A New Insight into Iron Profile for the Diagnosis of Parkinson's Disease.
    Tripathi CB; Gangania M; Kushwaha S; Agarwal R
    Ann Indian Acad Neurol; 2021; 24(2):234-238. PubMed ID: 34220068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changed transferrin sialylation in Parkinson's disease.
    van Kamp GJ; Mulder K; Kuiper M; Wolters EC
    Clin Chim Acta; 1995 Mar; 235(2):159-67. PubMed ID: 7554270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meta-analysis of the association between serum iron levels and Parkinson's disease: Evidence from 11 publications.
    Jiao J; Guo H; He Y; Wang J; Yuan J; Hu W
    Brain Res; 2016 Sep; 1646():490-493. PubMed ID: 27372885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.